| Overview |
| bsm-62616r |
| NAT1 Recombinant Antibody |
| WB, Flow-Cyt, ICC/IF |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human NAT1 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 9 |
| P18440 |
| AAC1; Arylamide acetylase 1; mNAT; N acetyltransferase type 1; nat1. |
| Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens. |
| Application Dilution |
| WB |
1:300-5000 |
| Flow-Cyt |
FCM1:20-100 |
| ICC/IF |
IFICC1:50-200 |
Powered by Bioz